# A Study to Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)

> **NCT03574532** · — · COMPLETED · sponsor: **Janssen-Cilag International NV** · enrollment: 118 (actual)

## Conditions studied

- Respiratory Tract Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03574532
- **Lead sponsor:** Janssen-Cilag International NV
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-27
- **Primary completion:** 2019-01-21
- **Final completion:** 2019-01-21
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2021-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03574532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03574532, "A Study to Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03574532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*